ACTIVE_NOT_RECRUITING

High Resolution Micro OCT Imaging

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to learn about using the imaging to make images of the lungs and nose with the long-term goal of the research leading to potential treatments and new therapies for patients with cystic fibrosis.

Official Title

Imaging of Human Epithelial Airway Using a High Resolution Micro OCT Catheter (Functional Anatomic Imaging of CF Patients With Early Lung Disease Using Micro OCT)

Quick Facts

Study Start:2016-04-15
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT03256773

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients diagnosed with CF or healthy normal controls with no respiratory disease
  2. * Patients must be over the age of 14
  3. * Patient must be able to give informed consent
  1. * Patients with recent respiratory infection requiring antibiotics or corticosteroids in the last 4 weeks (excluding routine perioperative antibiotics)
  2. * Patients with major sinus surgery that will alter the nasal anatomy and preclude imaging of the nares
  3. * Any condition that in the opinion of the investigator will alter the safety of pilot testing in the operating room
  4. * Female subjects who are pregnant

Contacts and Locations

Principal Investigator

Steven M Rowe
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35233
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Steven M Rowe, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-04-15
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2016-04-15
Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cystic Fibrosis
  • COPD
  • PCD - Primary Ciliary Dyskinesia
  • Covid19
  • Sinusitis